{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:45Z","timestamp":1791920025527,"version":"4.3.4"},"reference-count":111,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>With the escalation of viral infections in recent decades, including the COVID-\n19 pandemic, viral infectious diseases have increasingly become a global concern, attracting\nsignificant attention. Among many viral epidemics, the dengue virus, an RNA virus\nfrom the Flaviviridae family, has been reported by the WHO as one of the most prevalent\nmosquito-borne diseases, infecting roughly 400 million people yearly and spreading\nacross all continents worldwide. In the last two decades, researchers from academia and\nindustry have diligently studied many aspects of the virus, including its structure, life cycle,\npotential therapeutic agents, and vaccines. Dengvaxia&lt;sup&gt;\u00ae&lt;\/sup&gt; and Qdenga&lt;sup&gt;\u00ae&lt;\/sup&gt;, approved vaccines\nfor DENV-4, have been a milestone in dengue prevention and treatment. However,\nthese vaccines have some noticeable drawbacks, including Dengvaxia&lt;sup&gt;\u00ae&lt;\/sup&gt; being a monovalent\nvaccine against DENV-4 with a risk of severe dengue infection following the first\nuse, Qdenga&lt;sup&gt;\u00ae&lt;\/sup&gt; being mainly effective for all 4 serotypes only in the cases of previously infected\npatients while being effective against only DENV-1 and DENV-2 in dengue-na\u00efve\npatients. Additionally, no drug against dengue has been approved. Thus, numerous screening\ncampaigns have been conducted on both natural and synthesized substances to search\nfor anti-dengue agents, especially those targeting the virus's key protease (NS2B\/NS3), to\nmitigate the dengue fever epidemic. As hit screening is only the first step in the drug discovery\nand development cycle, subsequent in-depth analyses (using a wide range of approaches\nfrom computational simulations to protein-ligand co-crystallization) have been\nconducted to provide more insights into the characteristics of optimal DENV NS2B\/NS3\nprotease inhibitors. This review discusses recent discoveries in the search for novel inhibitors\nand highlights the importance of understanding the structural relationship between\nhits and the NS2B\/NS3 protease for effective lead optimization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673343582241229131338","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T02:16:09Z","timestamp":1738030569000},"page":"2721-2757","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Achievements and Approaches in the Search for Small-Molecule Dengue NS2B\/NS3 Inhibitors"],"prefix":"10.2174","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-9614","authenticated-orcid":true,"given":"Khac-Minh","family":"Thai","sequence":"first","affiliation":[{"name":"University of Health Sciences, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam"},{"name":"Research Center for Discovery and Development of Healthcare Products, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6716-9447","authenticated-orcid":true,"given":"Cuong Quoc","family":"Duong","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-9853","authenticated-orcid":true,"given":"Tan Thanh","family":"Mai","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5105-9710","authenticated-orcid":true,"given":"Minh-Tri","family":"Le","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam"},{"name":"Research Center for Discovery and Development of Healthcare Products, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam"},{"name":"Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4976-0436","authenticated-orcid":true,"given":"Van-Thanh","family":"Tran","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-1623","authenticated-orcid":true,"given":"Phuoc-Vinh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam"},{"name":"Research Center for Discovery and Development of Healthcare Products, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7285-4252","authenticated-orcid":true,"given":"Lam-Truong","family":"Tuong","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","volume":"163","author":"Lim S.P.","year":"2019","unstructured":"Lim S.P.; Dengue drug discovery: Progress, challenges and outlook. Antiviral Res  2019,163,156-178","journal-title":"Antiviral Res"},{"key":"ref=2","year":"2023","unstructured":"WHO Dengue and severe dengue.  Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue (accessed 13\/12\/2023).2023"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tim.2013.12.011","volume":"22","author":"Messina J.P.","year":"2014","unstructured":"Messina J.P.; Brady O.J.; Scott T.W.; Zou C.; Pigott D.M.; Duda K.A.; Bhatt S.; Katzelnick L.; Howes R.E.; Battle K.E.; Simmons C.P.; Hay S.I.; Global spread of dengue virus types: Mapping the 70 year history. Trends Microbiol  2014,22(3),138-146","journal-title":"Trends Microbiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10096-018-3375-7","volume":"38","author":"Sukhralia S.","year":"2019","unstructured":"Sukhralia S.; Verma M.; Gopirajan S.; Dhanaraj P.S.; Lal R.; Mehla N.; Kant C.R.; From dengue to Zika: The wide spread of mosquito-borne arboviruses. Eur J Clin Microbiol Infect Dis  2019,38(1),3-14","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=5","author":"Control E.C.D.P.a.","year":"2023","unstructured":"Control E.C.D.P.a.; Dengue worldwide overview.  Available from:  https:\/\/www.ecdc.europa.eu\/en\/dengue-monthly (accessed 13\/12\/2023).2023"},{"key":"ref=6","year":"2024","unstructured":"FDA DENGVAXIA  Available from:  https:\/\/www.fda.gov\/vaccines-blood-biologics\/dengvaxia (accessed 12\/10\/2024)2024"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"001831","DOI":"10.1099\/jgv.0.001831","volume":"104","author":"Pintado Silva J.","year":"2023","unstructured":"Pintado Silva J.; Fernandez-Sesma A.; Challenges on the development of a dengue vaccine: A comprehensive review of the state of the art. J Gen Virol  2023,104(3),001831","journal-title":"J Gen Virol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7006a1","volume":"70","author":"Paz-Bailey G.","year":"2021","unstructured":"Paz-Bailey G.; Adams L.; Wong J.M.; Poehling K.A.; Chen W.H.; McNally V.; Atmar R.L.; Waterman S.H.; Dengue Vaccine: Recommendations of the advisory committee on immunization practices, United States, 2021. MMWR Recomm Rep  2021,70(6),1-16","journal-title":"MMWR Recomm Rep"},{"key":"ref=9","unstructured":"WHO prequalifies new dengue vaccine.  Available from:  https:\/\/www.who.int\/news\/item\/15-05-2024-who-prequalifies-new-dengue-vaccine (accessed 12\/10\/2024)."},{"key":"ref=10","year":"2023","unstructured":"Takeda Takeda Announces Voluntary Withdrawal of U.S. Biologics License Application (BLA) for Dengue Vaccine Candidate TAK-003.  Available from: https:\/\/www. takeda.com\/newsroom\/statements\/2023\/takeda-announces-voluntary-withdrawal-of-us-biologics-license-application-for-dengue-vaccine-candidate-tak-003\/ (accessed 12\/10\/2024).2023"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","volume":"12","author":"Tricou V.","year":"2024","unstructured":"Tricou V.; Yu D.; Reynales H.; Biswal S.; Saez-Llorens X.; Sirivichayakul C.; Lopez P.; Borja-Tabora C.; Bravo L.; Kosalaraksa P.; Vargas L.M.; Alera M.T.; Rivera L.; Watanaveeradej V.; Dietze R.; Fernando L.; Wickramasinghe V.P.; Moreira E.D.; Fernando A.D.; Gunasekera D.; Luz K.; Oliveira A.L.; Tuboi S.; Escudero I.; Hutagalung Y.; Lloyd E.; Rauscher M.; Zent O.; Folschweiller N.; LeFevre I.; Espinoza F.; Wallace D.; Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4\u00b75-year results from a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Glob Health  2024,12(2),e257-e270","journal-title":"Lancet Glob Health"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ejmech.2019.05.010","volume":"176","author":"Dighe S.N.","year":"2019","unstructured":"Dighe S.N.; Ekwudu O.; Dua K.; Chellappan D.K.; Katavic P.L.; Collet T.A.; Recent update on anti-dengue drug discovery. Eur J Med Chem  2019,176,431-455","journal-title":"Eur J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"113362","DOI":"10.1016\/j.phytochem.2022.113362","volume":"202","author":"Saqallah F.G.","year":"2022","unstructured":"Saqallah F.G.; Abbas M.A.; Wahab H.A.; Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b\/NS3 protease. Phytochemistry  2022,202,113362","journal-title":"Phytochemistry"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","volume":"118","author":"Luo D.","year":"2015","unstructured":"Luo D.; Vasudevan S.G.; Lescar J.; The flavivirus NS2B\u2013NS3 protease\u2013helicase as a target for antiviral drug development. Antiviral Res  2015,118,148-158","journal-title":"Antiviral Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/bs.enz.2021.07.006","volume":"49","author":"Knyazhanskaya E.","year":"2021","unstructured":"Knyazhanskaya E.; Morais M.C.; Choi K.H.; Flavivirus enzymes and their inhibitors. Enzymes  2021,49,265-303","journal-title":"Enzymes"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.3390\/molecules19068151","volume":"19","author":"Teixeira R.","year":"2014","unstructured":"Teixeira R.; Pereira W.; Oliveira A.; Da Silva A.; De Oliveira A.; Da Silva M.; Da Silva C.; De Paula S.; Natural products as source of potential dengue antivirals. Molecules  2014,19(6),8151-8176","journal-title":"Molecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/26895293.2020.1856192","volume":"14","author":"Lim S.Y.M.","year":"2021","unstructured":"Lim S.Y.M.; Chieng J.Y.; Pan Y.; Recent insights on anti-dengue virus (DENV) medicinal plants: Review on in vitro, in vivo and in silico discoveries. All Life  2021,14(1),1-33","journal-title":"All Life"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1061937","DOI":"10.3389\/fcimb.2023.1061937","volume":"13","author":"Norshidah H.","year":"2023","unstructured":"Norshidah H.; Leow C.H.; Ezleen K.E.; Wahab H.A.; Vignesh R.; Rasul A.; Lai N.S.; Assessing the potential of NS2B\/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach. Front Cell Infect Microbiol  2023,13,1061937","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1099\/jgv.0.000672","volume":"98","author":"Simmonds P.","year":"2017","unstructured":"Simmonds P.; Becher P.; Bukh J.; Gould E.A.; Meyers G.; Monath T.; Muerhoff S.; Pletnev A.; Rico-Hesse R.; Smith D.B.; Stapleton J.T.; Consortium I.R.; Ictv report consortium ICTV virus taxonomy profile. Flaviviridae J Gen Virol  2017,98(1),2-3","journal-title":"Flaviviridae J Gen Virol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/pgmj.2004.019638","volume":"80","author":"Malavige G.N.","year":"2004","unstructured":"Malavige G.N.; Fernando S.; Fernando D.J.; Seneviratne S.L.; Dengue viral infections. Postgrad Med J  2004,80(948),588-601","journal-title":"Postgrad Med J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1248\/cpb.55.340","volume":"55","author":"Kim Y.G.","year":"2007","unstructured":"Kim Y.G.; Thai K.M.; Song J.; Kim K.K.; Park H.J.; Identification of novel ligands for the Z-DNA binding protein by structure-based virtual screening. Chem Pharm Bull  2007,55(2),340-342","journal-title":"Chem Pharm Bull"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s11224-022-02000-3","volume":"33","author":"Lam T.P.","year":"2022","unstructured":"Lam T.P.; Nguyen D.N.; Mai T.T.; Tran T.D.; Le M.T.; Huynh P.N.H.; Nguyen D.T.; Tran V.H.; Trinh D.T.T.; Truong P.; Vo C.V.T.; Thai K.M.; Exploration of chalcones as 3-chymotrypsin-like protease (3CLpro) inhibitors of SARS-CoV-2 using computational approaches. Struct Chem  2022,33(5),1707-1725","journal-title":"Struct Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"11570","DOI":"10.3390\/ijms231911570","volume":"23","author":"Lam T.P.","year":"2022","unstructured":"Lam T.P.; Tran V.H.; Mai T.T.; Lai N.V.T.; Dang B.T.N.; Le M.T.; Tran T.D.; Trinh D.T.T.; Thai K.M.; Identification of diosmin and flavin adenine dinucleotide as repurposing treatments for monkeypox virus: A computational study. Int J Mol Sci  2022,23(19),11570","journal-title":"Int J Mol Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/1062936X.2020.1837239","volume":"31","author":"Le M.T.","year":"2020","unstructured":"Le M.T.; Mai T.T.; Huynh P.N.H.; Tran T.D.; Thai K.M.; Nguyen Q.T.; Structure-based discovery of interleukin-33 inhibitors: A pharmacophore modelling, molecular docking, and molecular dynamics simulation approach. SAR QSAR Environ Res  2020,31(12),883-904","journal-title":"SAR QSAR Environ Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jtbi.2015.08.019","volume":"385","author":"Thai K.M.","year":"2015","unstructured":"Thai K.M.; Le D.P.; Tran N.V.K.; Nguyen T.T.H.; Tran T.D.; Le M.T.; Computational assay of Zanamivir binding affinity with original and mutant influenza neuraminidase 9 using molecular docking. J Theor Biol  2015,385,31-39","journal-title":"J Theor Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"14003","DOI":"10.1080\/07391102.2023.2193990","volume":"41","author":"Tran Q.H.","year":"2023","unstructured":"Tran Q.H.; Cao H.N.; Nguyen D.N.; Tran T.T.N.; Le M.T.; Nguyen Q.T.; Tran V.T.; Tran V.H.; Thai K.M.; Targeting Olokizumab-Interleukin 6 interaction interface to discover novel IL-6 inhibitors. J Biomol Struct Dyn  2023,41(23),14003-14015","journal-title":"J Biomol Struct Dyn"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/1062936X.2022.2132536","volume":"33","author":"Tran T.T.N.","year":"2022","unstructured":"Tran T.T.N.; Tran Q.H.; Nguyen Q.T.; Le M.T.; Trinh D.T.T.; Tran V.H.; Thai K.M.; LY3041658\/interleukin-8 complex structure as targets for IL-8 small molecule inhibitors discovery using a combination of in silico methods. SAR QSAR Environ Res  2022,33(10),753-778","journal-title":"SAR QSAR Environ Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mjafi.2014.09.011","volume":"71","author":"Mustafa M.S.","year":"2015","unstructured":"Mustafa M.S.; Rasotgi V.; Jain S.; Gupta V.; Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India  2015,71(1),67-70","journal-title":"Med J Armed Forces India"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3390\/v13101967","volume":"13","author":"Nanaware N.","year":"2021","unstructured":"Nanaware N.; Banerjee A.; Mullick Bagchi S.; Bagchi P.; Mukherjee A.; Dengue virus infection: A tale of viral exploitations and host responses. Viruses  2021,13(10),1967","journal-title":"Viruses"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cell.2015.07.005","volume":"162","author":"Diamond M.S.","year":"2015","unstructured":"Diamond M.S.; Pierson T.C.; Molecular insight into dengue virus pathogenesis and its implications for disease control. Cell  2015,162(3),488-492","journal-title":"Cell"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/antiox10030395","volume":"10","author":"Cheng C.C.","year":"2021","unstructured":"Cheng C.C.; Sofiyatun E.; Chen W.J.; Wang L.C.; Life as a vector of dengue virus: the antioxidant strategy of mosquito cells to survive viral infection. Antioxidants  2021,10(3),395","journal-title":"Antioxidants"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.antiviral.2009.11.009","volume":"87","author":"Bollati M.","year":"2010","unstructured":"Bollati M.; Alvarez K.; Assenberg R.; Baronti C.; Canard B.; Cook S.; Coutard B.; Decroly E.; de Lamballerie X.; Gould E.A.; Grard G.; Grimes J.M.; Hilgenfeld R.; Jansson A.M.; Malet H.; Mancini E.J.; Mastrangelo E.; Mattevi A.; Milani M.; Moureau G.; Neyts J.; Owens R.J.; Ren J.; Selisko B.; Speroni S.; Steuber H.; Stuart D.I.; Unge T.; Bolognesi M.; Structure and functionality in flavivirus NS-proteins: Perspectives for drug design. Antiviral Res  2010,87(2),125-148","journal-title":"Antiviral Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"959727","DOI":"10.3389\/fcimb.2022.959727","volume":"12","author":"Li Q.","year":"2022","unstructured":"Li Q.; Kang C.; Dengue virus NS4B protein as a target for developing antivirals. Front Cell Infect Microbiol  2022,12,959727","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"104900","DOI":"10.1016\/j.antiviral.2020.104900","volume":"182","author":"Phoo W.W.","year":"2020","unstructured":"Phoo W.W.; El Sahili A.; Zhang Z.; Chen M.W.; Liew C.W.; Lescar J.; Vasudevan S.G.; Luo D.; Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS3. Antiviral Res  2020,182,104900","journal-title":"Antiviral Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1128\/JVI.01788-07","volume":"82","author":"Luo D.","year":"2008","unstructured":"Luo D.; Xu T.; Hunke C.; Gr\u00fcber G.; Vasudevan S.G.; Lescar J.; Crystal structure of the NS3 protease-helicase from dengue virus. J Virol  2008,82(1),173-183","journal-title":"J Virol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0042-6822(89)90639-9","volume":"171","author":"Bazan J.F.","year":"1989","unstructured":"Bazan J.F.; Fletterick R.J.; Detection of a trypsin-like serine protease domain in flaviviruses and pestviruses. Virology  1989,171(2),637-639","journal-title":"Virology"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/B978-0-12-809712-0.00006-X","author":"Tomar S.","year":"2017","unstructured":"Tomar S.; Mudgal R.; Fatma B.; Chapter 6 - Flavivirus protease: An antiviral target.Viral Proteases and Their Inhibitors. Gupta S.P. Ed.; Academic Press  2017,137-161","journal-title":"Academic Press"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/v14071440","volume":"4","author":"Quek J-P.","year":"2022","unstructured":"Quek J-P.; Ser Z.; Chew B.L.A.; Li X.; Wang L.; Sobota R.M.; Luo D.; Phoo W.W.; Dynamic interactions of post cleaved NS2B cofactor and NS3 protease identified by integrative structural approaches. Viruses  2022,4(7),1440","journal-title":"Viruses"},{"key":"ref=39","first-page":"2527","volume":"21","author":"Li Q.","year":"2020","unstructured":"Li Q.; Kang C.; Insights into structures and dynamics of flavivirus proteases from NMR studies.  2020,21(7),2527"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s42003-023-05584-6","volume":"6","author":"Agback T.","year":"2023","unstructured":"Agback T.; Lesovoy D.; Han X.; Lomzov A.; Sun R.; Sandalova T.; Orekhov V.Y.; Achour A.; Agback P.; Combined NMR and molecular dynamics conformational filter identifies unambiguously dynamic ensembles of Dengue protease NS2B\/NS3pro. Commun Biol  2023,6(1),1193","journal-title":"Commun Biol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e0134823","DOI":"10.1371\/journal.pone.0134823","volume":"10","author":"Gupta G.","year":"2015","unstructured":"Gupta G.; Lim L.; Song J.; NMR and MD studies reveal that the isolated dengue ns3 protease is an intrinsically disordered chymotrypsin fold which absolutely requests NS2B for correct folding and functional dynamics. PLoS One  2015,10(8),e0134823","journal-title":"PLoS One"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1128\/JVI.06225-11","volume":"86","author":"Noble C.G.","year":"2012","unstructured":"Noble C.G.; Seh C.C.; Chao A.T.; Shi P.Y.; Ligand-bound structures of the dengue virus protease reveal the active conformation. J Virol  2012,86(1),438-446","journal-title":"J Virol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"13708","DOI":"10.1128\/JVI.78.24.13708-13716.2004","volume":"78","author":"Niyomrattanakit P.","year":"2004","unstructured":"Niyomrattanakit P.; Winoyanuwattikun P.; Chanprapaph S.; Angsuthanasombat C.; Panyim S.; Katzenmeier G.; Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation. J Virol  2004,78(24),13708-13716","journal-title":"J Virol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","volume":"58","author":"Behnam M.A.M.","year":"2015","unstructured":"Behnam M.A.M.; Graf D.; Bartenschlager R.; Zlotos D.P.; Klein C.D.; Discovery of nanomolar dengue and west nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue. J Med Chem  2015,58(23),9354-9370","journal-title":"J Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1021\/cb400612h","volume":"8","author":"Yildiz M.","year":"2013","unstructured":"Yildiz M.; Ghosh S.; Bell J.A.; Sherman W.; Hardy J.A.; Allosteric inhibition of the NS2B-NS3 protease from dengue virus. ACS Chem Biol  2013,8(12),2744-2752","journal-title":"ACS Chem Biol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1021\/jacs.9b02505","volume":"141","author":"Yao Y.","year":"2019","unstructured":"Yao Y.; Huo T.; Lin Y.L.; Nie S.; Wu F.; Hua Y.; Wu J.; Kneubehl A.R.; Vogt M.B.; Rico-Hesse R.; Song Y.; Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of flavivirus NS2B-NS3 protease. J Am Chem Soc  2019,141(17),6832-6836","journal-title":"J Am Chem Soc"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e1006411","DOI":"10.1371\/journal.ppat.1006411","volume":"13","author":"Brecher M.","year":"2017","unstructured":"Brecher M.; Li Z.; Liu B.; Zhang J.; Koetzner C.A.; Alifarag A.; Jones S.A.; Lin Q.; Kramer L.D.; Li H.; A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease. PLoS Pathog  2017,13(5),e1006411","journal-title":"PLoS Pathog"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-981-10-8727-1_13","volume":"1062","author":"Nitsche C.","year":"2018","unstructured":"Nitsche C.; Strategies towards protease inhibitors for emerging flaviviruses. Adv Exp Med Biol  2018,1062,175-186","journal-title":"Adv Exp Med Biol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"25677","DOI":"10.1021\/acsomega.0c00039","volume":"5","author":"Lim L.","year":"2020","unstructured":"Lim L.; Dang M.; Roy A.; Kang J.; Song J.; Curcumin allosterically inhibits the dengue NS2B-NS3 protease by disrupting its active conformation. ACS Omega  2020,5(40),25677-25686","journal-title":"ACS Omega"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.1021\/acs.jmedchem.9b01697","volume":"62","author":"Millies B.","year":"2019","unstructured":"Millies B.; von Hammerstein F.; Gellert A.; Hammerschmidt S.; Barthels F.; G\u00f6ppel U.; Immerheiser M.; Elgner F.; Jung N.; Basic M.; Kersten C.; Kiefer W.; Bodem J.; Hildt E.; Windbergs M.; Hellmich U.A.; Schirmeister T.; Proline-based allosteric inhibitors of zika and dengue virus NS2B\/NS3 proteases. J Med Chem  2019,62(24),11359-11382","journal-title":"J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1021\/acsomega.1c05569","volume":"7","author":"Dang M.","year":"2022","unstructured":"Dang M.; Lim L.; Roy A.; Song J.; Myricetin allosterically inhibits the dengue NS2B-NS3 protease by disrupting the active and locking the inactive conformations. ACS Omega  2022,7(3),2798-2808","journal-title":"ACS Omega"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1128\/AAC.03543-14","volume":"59","author":"Wu H.","year":"2015","unstructured":"Wu H.; Bock S.; Snitko M.; Berger T.; Weidner T.; Holloway S.; Kanitz M.; Diederich W.E.; Steuber H.; Walter C.; Hofmann D.; Wei\u00dfbrich B.; Spannaus R.; Acosta E.G.; Bartenschlager R.; Engels B.; Schirmeister T.; Bodem J.; Novel dengue virus NS2B\/NS3 protease inhibitors. Antimicrob Agents Chemother  2015,59(2),1100-1109","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bmc.2014.12.015","volume":"23","author":"de Sousa L.R.F.","year":"2015","unstructured":"de Sousa L.R.F.; Wu H.; Nebo L.; Fernandes J.B.; da Silva M.F.G.F.; Kiefer W.; Kanitz M.; Bodem J.; Diederich W.E.; Schirmeister T.; Vieira P.C.; Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies. Bioorg Med Chem  2015,23(3),466-470","journal-title":"Bioorg Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"113767","DOI":"10.1016\/j.ejmech.2021.113767","volume":"225","author":"Nie S.","year":"2021","unstructured":"Nie S.; Zhao J.; Wu X.; Yao Y.; Wu F.; Lin Y.L.; Li X.; Kneubehl A.R.; Vogt M.B.; Rico-Hesse R.; Song Y.; Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease. Eur J Med Chem  2021,225,113767","journal-title":"Eur J Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1021\/acs.jmedchem.0c02070","volume":"64","author":"Nie S.","year":"2021","unstructured":"Nie S.; Yao Y.; Wu F.; Wu X.; Zhao J.; Hua Y.; Wu J.; Huo T.; Lin Y.L.; Kneubehl A.R.; Vogt M.B.; Ferreon J.; Rico-Hesse R.; Song Y.; Synthesis, structure\u2013activity relationships, and antiviral activity of allosteric inhibitors of flavivirus NS2B\u2013NS3 protease. J Med Chem  2021,64(5),2777-2800","journal-title":"J Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/cr.2017.88","volume":"27","author":"Li Z.","year":"2017","unstructured":"Li Z.; Brecher M.; Deng Y.Q.; Zhang J.; Sakamuru S.; Liu B.; Huang R.; Koetzner C.A.; Allen C.A.; Jones S.A.; Chen H.; Zhang N.N.; Tian M.; Gao F.; Lin Q.; Banavali N.; Zhou J.; Boles N.; Xia M.; Kramer L.D.; Qin C.F.; Li H.; Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res  2017,27(8),1046-1064","journal-title":"Cell Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3390\/plants10102183","volume":"10","author":"Eberle R.J.","year":"2021","unstructured":"Eberle R.J.; Olivier D.S.; Amaral M.S.; Willbold D.; Arni R.K.; Coronado M.A.; Promising natural compounds against flavivirus proteases: citrus flavonoids hesperetin and hesperidin. Plants  2021,10(10),2183","journal-title":"Plants"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"116392","DOI":"10.1016\/j.bmc.2021.116392","volume":"47","author":"Maus H.","year":"2021","unstructured":"Maus H.; Barthels F.; Hammerschmidt S.J.; Kopp K.; Millies B.; Gellert A.; Ruggieri A.; Schirmeister T.; SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B\/NS3 proteases. Bioorg Med Chem  2021,47,116392","journal-title":"Bioorg Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.2147\/DDDT.S94207","volume":"9","author":"Koh-Stenta X.","year":"2015","unstructured":"Koh-Stenta X.; Joy J.; Wang S.F.; Kwek P.; Wee J.; Wan K.F.; Gayen S.; Chen A.; Kang C.; Lee M.A.; Poulsen A.; Vasudevan S.; Hill J.; Nacro K.; Identification of covalent active site inhibitors of dengue virus protease. Drug Des Devel Ther  2015,9,6389-6399","journal-title":"Drug Des Devel Ther"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","volume":"150","author":"Li Z.","year":"2018","unstructured":"Li Z.; Sakamuru S.; Huang R.; Brecher M.; Koetzner C.A.; Zhang J.; Chen H.; Qin C.; Zhang Q.Y.; Zhou J.; Kramer L.D.; Xia M.; Li H.; Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease. Antiviral Res  2018,150,217-225","journal-title":"Antiviral Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1016\/j.bmcl.2005.12.075","volume":"16","author":"Kiat T.S.","year":"2006","unstructured":"Kiat T.S.; Pippen R.; Yusof R.; Ibrahim H.; Khalid N.; Rahman N.A.; Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg Med Chem Lett  2006,16(12),3337-3340","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/pharmaceutics15030803","volume":"15","author":"Coronado M.A.","year":"2023","unstructured":"Coronado M.A.; Gering I.; Sevenich M.; Olivier D.S.; Mastalipour M.; Amaral M.S.; Willbold D.; Eberle R.J.; The importance of epigallocatechin as a scaffold for drug development against flaviviruses. Pharmaceutics  2023,15(3),803","journal-title":"Pharmaceutics"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/aps.2015.56","volume":"36","author":"Wu D.","year":"2015","unstructured":"Wu D.; Mao F.; Ye Y.; Li J.; Xu C.; Luo X.; Chen J.; Shen X.; Policresulen, a novel NS2B\/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells. Acta Pharmacol Sin  2015,36(9),1126-1136","journal-title":"Acta Pharmacol Sin"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"19205","DOI":"10.1021\/ja208435s","volume":"133","author":"de la Cruz L.","year":"2011","unstructured":"de la Cruz L.; Nguyen T.H.D.; Ozawa K.; Shin J.; Graham B.; Huber T.; Otting G.; Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: Fold analysis by pseudocontact shifts. J Am Chem Soc  2011,133(47),19205-19215","journal-title":"J Am Chem Soc"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1021\/jm900448m","volume":"52","author":"Ekonomiuk D.","year":"2009","unstructured":"Ekonomiuk D.; Su X.C.; Ozawa K.; Bodenreider C.; Lim S.P.; Otting G.; Huang D.; Caflisch A.; Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics. J Med Chem  2009,52(15),4860-4868","journal-title":"J Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1021\/acs.jmedchem.0c02042","volume":"64","author":"K\u00fchl N.","year":"2021","unstructured":"K\u00fchl N.; Leuthold M.M.; Behnam M.A.M.; Klein C.D.; Beyond basicity: discovery of nonbasic denv-2 protease inhibitors with potent activity in cell culture. J Med Chem  2021,64(8),4567-4587","journal-title":"J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1021\/acsmedchemlett.1c00653","volume":"13","author":"Lin X.","year":"2022","unstructured":"Lin X.; Cheng J.; Wu Y.; Zhang Y.; Jiang H.; Wang J.; Wang X.; Cheng M.; Identification and in silico binding study of a highly potent denv NS2B-NS3 covalent inhibitor. ACS Med Chem Lett  2022,13(4),599-607","journal-title":"ACS Med Chem Lett"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bmc.2012.10.058","volume":"21","author":"Lai H.","year":"2013","unstructured":"Lai H.; Dou D.; Aravapalli S.; Teramoto T.; Lushington G.H.; Mwania T.M.; Alliston K.R.; Eichhorn D.M.; Padmanabhan R.; Groutas W.C.; Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: Potent inhibitors of Dengue and West Nile virus NS2B\/NS3 proteases. Bioorg Med Chem  2013,21(1),102-113","journal-title":"Bioorg Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1021\/acsomega.8b02861","volume":"4","author":"Saleem H.N.","year":"2019","unstructured":"Saleem H.N.; Batool F.; Mansoor H.J.; Shahzad-ul-Hussan S.; Saeed M.; Inhibition of dengue virus protease by eugeniin, isobiflorin, and biflorin isolated from the flower buds of syzygium aromaticum (cloves). ACS Omega  2019,4(1),1525-1533","journal-title":"ACS Omega"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.antiviral.2012.10.009","volume":"97","author":"Lai H.","year":"2013","unstructured":"Lai H.; Sridhar Prasad G.; Padmanabhan R.; Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro. Antiviral Res  2013,97(1),74-80","journal-title":"Antiviral Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1016\/j.bmc.2011.10.061","volume":"19","author":"Nitsche C.","year":"2011","unstructured":"Nitsche C.; Steuer C.; Klein C.D.; Arylcyanoacrylamides as inhibitors of the dengue and west nile virus proteases. Bioorg Med Chem  2011,19(24),7318-7337","journal-title":"Bioorg Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.antiviral.2010.12.006","volume":"89","author":"Tomlinson S.M.","year":"2011","unstructured":"Tomlinson S.M.; Watowich S.J.; Anthracene-based inhibitors of dengue virus NS2B\u2013NS3 protease. Antiviral Res  2011,89(2),127-135","journal-title":"Antiviral Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10822-011-9418-0","volume":"25","author":"Knehans T.","year":"2011","unstructured":"Knehans T.; Sch\u00fcller A.; Doan D.N.; Nacro K.; Hill J.; G\u00fcntert P.; Madhusudhan M.S.; Weil T.; Vasudevan S.G.; Structure-guided fragment-based in silico drug design of dengue protease inhibitors. J Comput Aided Mol Des  2011,25(3),263-274","journal-title":"J Comput Aided Mol Des"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1128\/AAC.01508-07","volume":"52","author":"Mueller N.H.","year":"2008","unstructured":"Mueller N.H.; Pattabiraman N.; Ansarah-Sobrinho C.; Viswanathan P.; Pierson T.C.; Padmanabhan R.; Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen. Antimicrob Agents Chemother  2008,52(9),3385-3393","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ab.2009.08.013","volume":"395","author":"Bodenreider C.","year":"2009","unstructured":"Bodenreider C.; Beer D.; Keller T.H.; Sonntag S.; Wen D.; Yap L.; Yau Y.H.; Shochat S.G.; Huang D.; Zhou T.; Caflisch A.; Su X.C.; Ozawa K.; Otting G.; Vasudevan S.G.; Lescar J.; Lim S.P.; A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease. Anal Biochem  2009,395(2),195-204","journal-title":"Anal Biochem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbrc.2022.08.060","volume":"627","author":"Cheng J.","year":"2022","unstructured":"Cheng J.; Feng S.; Zhang Y.; Ding T.; Jiang H.; Zhang Z.; Wang J.; Wang X.; Cheng M.; Discovery of highly potent DENV NS2B-NS3 covalent inhibitors containing a phenoxymethylphenyl residue. Biochem Biophys Res Commun  2022,627,214-219","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12985-015-0248-x","volume":"12","author":"Raut R.","year":"2015","unstructured":"Raut R.; Beesetti H.; Tyagi P.; Khanna I.; Jain S.K.; Jeankumar V.U.; Yogeeswari P.; Sriram D.; Swaminathan S.; A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture. Virol J  2015,12(1),16","journal-title":"Virol J"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/10408347.2014.881250","volume":"45","author":"Olaru A.","year":"2015","unstructured":"Olaru A.; Bala C.; Jaffrezic-Renault N.; Aboul-Enein H.Y.; Surface plasmon resonance (SPR) biosensors in pharmaceutical analysis. Crit Rev Anal Chem  2015,45(2),97-105","journal-title":"Crit Rev Anal Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1002\/cmdc.202100246","volume":"16","author":"Kronenberger T.","year":"2021","unstructured":"Kronenberger T.; S\u00e1 Magalh\u00e3es Serafim M.; Kumar Tonduru A.; Gon\u00e7alves Maltarollo V.; Poso A.; Ligand accessibility insights to the dengue virus NS3-NS2B protease assessed by long-timescale molecular dynamics simulations. Chem Med Chem  2021,16(16),2524-2534","journal-title":"Chem Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/pro.5560040401","volume":"4","author":"Dill K.A.","year":"1995","unstructured":"Dill K.A.; Bromberg S.; Yue K.; Chan H.S.; Ftebig K.M.; Yee D.P.; Thomas P.D.; Principles of protein folding \u2014 A perspective from simple exact models. Protein Sci  1995,4(4),561-602","journal-title":"Protein Sci"},{"key":"ref=81","first-page":"349","volume":"27","author":"Najmi A.","year":"2022","unstructured":"Najmi A.; Javed S.A.; Al Bratty M.; Alhazmi H.A.; Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents. Nat Prod  2022,27(2),349","journal-title":"Nat Prod"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/1751-7915.13351","volume":"12","author":"Wright G.D.","year":"2019","unstructured":"Wright G.D.; Unlocking the potential of natural products in drug discovery. Microb Biotechnol  2019,12(1),55-57","journal-title":"Microb Biotechnol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/17460441.2019.1582639","volume":"14","author":"Li F.","year":"2019","unstructured":"Li F.; Wang Y.; Li D.; Chen Y.; Dou Q.P.; Are we seeing a resurgence in the use of natural products for new drug discovery? Expert Opin Drug Discov  2019,14(5),417-420","journal-title":"Expert Opin Drug Discov"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/B978-0-12-820472-6.00041-4","author":"Dzobo K.","year":"2022","unstructured":"Dzobo K.;  Comprehensive Pharmacology  2022,408-422","journal-title":"Comprehensive Pharmacology"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/molecules28030974","volume":"28","author":"Loeanurit N.","year":"2023","unstructured":"Loeanurit N.; Tuong T.L.; Nguyen V.K.; Vibulakhaophan V.; Hengphasatporn K.; Shigeta Y.; Ho S.X.; Chu J.J.H.; Rungrotmongkol T.; Chavasiri W.; Boonyasuppayakorn S.; Lichen-derived diffractaic acid inhibited dengue virus replication in a cell-based system. Molecules  2023,28(3),974","journal-title":"Molecules"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/1743-422X-8-560","volume":"8","author":"Zandi K.","year":"2011","unstructured":"Zandi K.; Teoh B.T.; Sam S.S.; Wong P.F.; Mustafa M.R.; AbuBakar S.; Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J  2011,8(1),560","journal-title":"Virol J"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1080\/07391102.2020.1734485","volume":"39","author":"Dwivedi V.D.","year":"2021","unstructured":"Dwivedi V.D.; Bharadwaj S.; Afroz S.; Khan N.; Ansari M.A.; Yadava U.; Tripathi R.C.; Tripathi I.P.; Mishra S.K.; Kang S.G.; Anti-dengue infectivity evaluation of bioflavonoid from Azadirachta indica by dengue virus serine protease inhibition. J Biomol Struct Dyn  2021,39(4),1417-1430","journal-title":"J Biomol Struct Dyn"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"366","DOI":"10.34172\/jhp.2020.46","volume":"9","author":"Jayadevappa M.K.","year":"2020","unstructured":"Jayadevappa M.K.; Karkera P.R.; Siddappa R.Y.; Telkar S.; Karunakara P.; Investigation of plant flavonoids as potential dengue protease inhibitors. Molecules  2020,9(4),366-373","journal-title":"Molecules"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00044-020-02660-y","volume":"30","author":"Ganji L.R.","year":"2021","unstructured":"Ganji L.R.; Gandhi L.; Musturi V.; Kanyalkar M.A.; Design, synthesis, and evaluation of different scaffold derivatives against NS2B-NS3 protease of dengue virus. Med Chem Res  2021,30(1),285-301","journal-title":"Med Chem Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"79","DOI":"10.47665\/tb.38.2.044","volume":"38","author":"y, S.; Liew S.Y.","year":"2021","unstructured":"y, S.; Liew S.Y.; Othman M.A.; Abdul Wahab S.M.; Hariono M.; Mohd Nawi M.S.; Abdul Wahab H.; Awang K.; Natural DENV-2 NS2B\/NS3 protease inhibitors from Myristica cinnamomea King. Trop Biomed  2021,38(2),79-84","journal-title":"Trop Biomed"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.antiviral.2018.12.002","volume":"162","author":"Balasubramanian A.","year":"2019","unstructured":"Balasubramanian A.; Pilankatta R.; Teramoto T.; Sajith A.M.; Nwulia E.; Kulkarni A.; Padmanabhan R.; Inhibition of dengue virus by curcuminoids. Antiviral Res  2019,162,71-78","journal-title":"Antiviral Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"294","DOI":"10.7150\/ijbs.6.294","volume":"6","author":"Muhamad M.","year":"2010","unstructured":"Muhamad M.; Kee L.Y.; Rahman N.A.; Yusof R.; Antiviral actions of flavanoid-derived compounds on dengue virus type-2. Int J Biol Sci  2010,6(3),294-302","journal-title":"Int J Biol Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"19059","DOI":"10.1038\/s41598-019-55723-5","volume":"9","author":"Bharadwaj S.","year":"2019","unstructured":"Bharadwaj S.; Lee K.E.; Dwivedi V.D.; Yadava U.; Panwar A.; Lucas S.J.; Pandey A.; Kang S.G.; Discovery of ganoderma lucidum triterpenoids as potential inhibitors against dengue virus NS2B-NS3 protease. Sci Rep  2019,9(1),19059","journal-title":"Sci Rep"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12906-018-2163-3","volume":"18","author":"Flores-Ocelotl M.R.","year":"2018","unstructured":"Flores-Ocelotl M.R.; Rosas-Murrieta N.H.; Moreno D.A.; Vallejo-Ruiz V.; Reyes-Leyva J.; Dom\u00ednguez F.; Santos-L\u00f3pez G.; Taraxacum officinale and Urtica dioica extracts inhibit dengue virus serotype 2 replication in vitro. BMC Complement Altern Med  2018,18(1),95","journal-title":"BMC Complement Altern Med"},{"key":"ref=95","first-page":"286","volume":"31","author":"Rothan H.A.","year":"2014","unstructured":"Rothan H.A.; Zulqarnain M.; Ammar Y.A.; Tan E.C.; Rahman N.A.; Yusof R.; Screening of antiviral activities in medicinal plants extracts against dengue virus using dengue NS2B-NS3 protease assay. Trop Biomed  2014,31(2),286-296","journal-title":"Trop Biomed"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2016.08.018","volume":"134","author":"Quintana V.M.","year":"2016","unstructured":"Quintana V.M.; Piccini L.E.; Panozzo Z\u00e9nere J.D.; Damonte E.B.; Ponce M.A.; Castilla V.; Antiviral activity of natural and synthetic \u03b2-carbolines against dengue virus. Antiviral Res  2016,134,26-33","journal-title":"Antiviral Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/md14080151","volume":"14","author":"Lee J.C.","year":"2016","unstructured":"Lee J.C.; Chang F.R.; Chen S.R.; Wu Y.H.; Hu H.C.; Wu Y.C.; Backlund A.; Cheng Y.B.; Anti-dengue virus constituents from formosan zoanthid palythoa mutuki. Mar Drugs  2016,14(8),151","journal-title":"Mar Drugs"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/v15061377","volume":"15","author":"Yi B.","year":"2023","unstructured":"Yi B.; Chew B.X.Z.; Chen H.; Lee R.C.H.; Fong Y.D.; Chin W.X.; Mok C.K.; Chu J.J.H.; Antiviral activity of catechin against dengue virus infection. Viruses  2023,15(6),1377","journal-title":"Viruses"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.3390\/molecules26103016","volume":"6","author":"Panda K.","year":"2021","unstructured":"Panda K.; Alagarasu K.; Patil P.; Agrawal M.; More A.; Kumar N.V.; Mainkar P.S.; Parashar D.; Cherian S.; In vitro antiviral activity of \u03b1-mangostin against dengue virus serotype-2 (DENV-2). Molecules  2021,6(10),3016","journal-title":"Molecules"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.antiviral.2016.08.014","volume":"134","author":"Balasubramanian A.","year":"2016","unstructured":"Balasubramanian A.; Manzano M.; Teramoto T.; Pilankatta R.; Padmanabhan R.; High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Antiviral Res  2016,134,6-16","journal-title":"Antiviral Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1099-1573(200003)14:2<89:AID-PTR569>3.0.CO;2-C","volume":"14","author":"S\u00e1nchez I.","year":"2000","unstructured":"S\u00e1nchez I.; G\u00f3mez-Garibay F.; Taboada J.; Ruiz B.H.; Antiviral effect of flavonoids on the dengue virus. Phytother Res  2000,14(2),89-92","journal-title":"Phytother Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1472-6882-12-214","volume":"12","author":"Zandi K.","year":"2012","unstructured":"Zandi K.; Teoh B.T.; Sam S.S.; Wong P.F.; Mustafa M.R.; AbuBakar S.; Novel antiviral activity of baicalein against dengue virus. BMC Complement Altern Med  2012,12(1),214","journal-title":"BMC Complement Altern Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"e10240","DOI":"10.1590\/1414-431x2020e10240","volume":"54","author":"Figueiredo G.G.","year":"2021","unstructured":"Figueiredo G.G.; Coronel O.A.; Trabuco A.C.; Baz\u00e1n D.E.; Russo R.R.; Alvarenga N.L.; Aquino V.H.; Steroidal saponins from the roots of Solanum sisymbriifolium Lam. (Solanaceae) have inhibitory activity against dengue virus and yellow fever virus. Braz J Med Biol Res  2021,54(7),e10240","journal-title":"Braz J Med Biol Res"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2016.12.014","volume":"139","author":"Panraksa P.","year":"2017","unstructured":"Panraksa P.; Ramphan S.; Khongwichit S.; Smith D.R.; Activity of andrographolide against dengue virus. Antiviral Res  2017,139,69-78","journal-title":"Antiviral Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"9919","DOI":"10.3390\/molecules18089919","volume":"18","author":"Brand\u00e3o G.","year":"2013","unstructured":"Brand\u00e3o G.; Kroon E.; Souza D.; Filho J.; Oliveira A.; Chemistry and antiviral activity of Arrabidaea pulchra (Bignoniaceae). Molecules  2013,18(8),9919-9932","journal-title":"Molecules"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12985-022-01751-z","volume":"19","author":"de Castro Barbosa E.","year":"2022","unstructured":"de Castro Barbosa E.; Alves T.M.A.; Kohlhoff M.; Jangola S.T.G.; Pires D.E.V.; Figueiredo A.C.C.; Alves \u00c9.A.R.; Calzavara-Silva C.E.; Sobral M.; Kroon E.G.; Rosa L.H.; Zani C.L.; de Oliveira J.G.; Searching for plant-derived antivirals against dengue virus and Zika virus. Virol J  2022,19(1),31","journal-title":"Virol J"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"Hewlings S.","year":"2017","unstructured":"Hewlings S.; Kalman D.; Curcumin: A review of its effects on human health. Foods  2017,6(10),92","journal-title":"Foods"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3390\/v12111242","volume":"12","author":"Jennings M.R.","year":"2020","unstructured":"Jennings M.R.; Parks R.J.; Curcumin as an antiviral agent. Viruses  2020,12(11),1242","journal-title":"Viruses"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/ijms23010259","volume":"23","author":"Macip G.","year":"2021","unstructured":"Macip G.; Garcia-Segura P.; Mestres-Truyol J.; Saldivar-Espinoza B.; Pujadas G.; Garcia-Vallv\u00e9 S.; A review of the current landscape of SARS-CoV-2 main protease inhibitors: Have we hit the bullseye yet? Int J Mol Sci  2021,23(1),259","journal-title":"Int J Mol Sci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3390\/ijms25031427","volume":"25","author":"Linn A.K.","year":"2024","unstructured":"Linn A.K.; Manopwisedjaroen S.; Kanjanasirirat P.; Borwornpinyo S.; Hongeng S.; Phanthong P.; Thitithanyanont A.; Unveiling the antiviral properties of panduratin a through SARS-CoV-2 infection modeling in cardiomyocytes. Int J Mol Sci  2024,25(3),1427","journal-title":"Int J Mol Sci"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3389\/fmicb.2016.00875","volume":"7","author":"Yamashita A.","year":"2016","unstructured":"Yamashita A.; Sakamoto T.; Sekizuka T.; Kato K.; Takasaki T.; Kuroda M.; DGV: Dengue genographic viewer. Front Microbiol  2016,7,875","journal-title":"Front Microbiol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673343582241229131338","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/238923\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673343582241229131338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:50:56Z","timestamp":1791877856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/238923\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":111,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673343582241229131338","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}